Invenomic Capital Management LP Lexaria Bioscience Corp. Transaction History
Invenomic Capital Management LP
- $1.75 Billion
- Q3 2024
A detailed history of Invenomic Capital Management LP transactions in Lexaria Bioscience Corp. stock. As of the latest transaction made, Invenomic Capital Management LP holds 475,773 shares of LEXX stock, worth $1.04 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
475,773
Previous 513,573
7.36%
Holding current value
$1.04 Million
Previous $1.43 Million
1.68%
% of portfolio
0.08%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding LEXX
# of Institutions
27Shares Held
1.06MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA150KShares$329,3560.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA109KShares$238,7580.0% of portfolio
-
Gen Trust, LLC60KShares$131,4000.01% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL44.9KShares$98,3310.0% of portfolio
-
State Street Corp Boston, MA39.3KShares$86,0690.0% of portfolio
About Lexaria Bioscience Corp.
- Ticker LEXX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,951,000
- Market Cap $13M
- Description
- Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...